For Reauthoring Preparedness Law, Congress Needs Advice On Next Public Health Emergency
Executive Summary
House Energy and Commerce members seek input as appropriate mix of incentives for next-generation, public-private ventures remains elusive.
You may also be interested in...
Consortium Costs Debated As BARDA, Industry Discuss Plans For Next Pandemic Response
BARDA’s consortium approach scrutinized as industry recovers from US Defense Production Act rated orders. Questions of sustainment fees, interruptible commercial activities explored during BioMaC Industry Day call as agency emphasizes need for proven capacity.
What To Do When Last Pandemic’s Answer To The Next Pandemic Falters: Point Fingers
US congressional ‘coronavirus crisis’ panel explores Emergent BioSolutions COVID-19 vaccine launch failures while scoring points about private sector support.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.